Fabio Palmieri holds a PhD in microbiology from the University of Neuchâtel and is passionate about the study of host-pathogen interactions. Currently a postdoctoral researcher, he is focusing on microbial interactions between pathogenic fungi and bacteria in the lung microbiota, with particular reference to Aspergillus fumigatus, the major pathogen of pulmonary aspergillosis. His work aims to use bacteria as biocontrol agents to inhibit the growth of fungal pathogens. Fabio Palmieri is also a visiting researcher in the Pneumology Laboratory at the CHUV, where he is studying the transcriptional changes that occur in Aspergillus fumigatus in in-vitro models of healthy differentiated primary bronchial epithelium and cystic fibrosis epithelium, in the presence or absence of antagonistic bacteria.
Present: : Friedrich Schiller Universität Jena: fabio.palmieri@uni-jena.de
Palmieri F, Estoppey A, House GL, Lohberger A, Bindschedler S, Chain PSG, Junier P. Oxalic acid, a molecule at the crossroads of bacterial-fungal interactions. Adv Appl Microbiol. 2019;106:49-77. doi: 10.1016/bs.aambs.2018.10.001. Epub 2018 Nov 27. PMID: 30798804.
Palmieri F, Koutsokera A, Bernasconi E, Junier P, von Garnier C, Ubags N. Recent Advances in Fungal Infections: From Lung Ecology to Therapeutic Strategies With a Focus on Aspergillus spp. Front Med (Lausanne). 2022 Mar 21;9:832510. doi: 10.3389/fmed.2022.832510. PMID: 35386908; PMCID: PMC8977413.
Palmieri F, Magnin M, Diserens J, Gresse M, Bernasconi E, Pernot J, Shanmuganathan A, Trompette A, Von Garnier C, Junier T, Neuenschwander S, Bindschedler S, Pagni M, Koutsokera A, Ubags N, Junier P. One-Step Soft Agar Enrichment and Isolation of Human Lung Bacteria Inhibiting the Germination of Aspergillus fumigatus conidia. Preprints 2023, 2023052247. https://doi.org/10.20944/preprints202305.2247.v1